{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T20:50:49Z","timestamp":1762980649512,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":110,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493990641"},{"type":"electronic","value":"9781493990658"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/978-1-4939-9065-8_1","type":"book-chapter","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T13:22:54Z","timestamp":1548940974000},"page":"3-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Basic Concepts in Viral Vector-Mediated Gene Therapy"],"prefix":"10.1007","author":[{"given":"Matthew J.","family":"Benskey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivette M.","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rhyomi L.","family":"Sellnow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aysegul","family":"Gezer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan C.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roslyn","family":"Vashon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fredric P.","family":"Manfredsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,1]]},"reference":[{"key":"1_CR1","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1073\/pnas.79.6.2077","volume":"79","author":"RJ Samulski","year":"1982","unstructured":"Samulski RJ, Berns KI, Tan M et al (1982) Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells. Proc Natl Acad Sci U S A 79:2077\u20132081","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR2","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/hum.2011.200","volume":"23","author":"L Samaranch","year":"2012","unstructured":"Samaranch L, Salegio EA, San Sebastian W et al (2012) Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther 23:382\u2013389","journal-title":"Hum Gene Ther"},{"key":"1_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/978-1-4939-3271-9_10","volume":"1382","author":"MJ Castle","year":"2016","unstructured":"Castle MJ, Turunen HT, Vandenberghe LH et al (2016) Controlling AAV tropism in the nervous system with natural and engineered capsids. Methods Mol Biol 1382:133\u2013149","journal-title":"Methods Mol Biol"},{"key":"1_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/ng1094-148","volume":"8","author":"MG Kaplitt","year":"1994","unstructured":"Kaplitt MG, Leone P, Samulski RJ et al (1994) Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 8:148\u2013154","journal-title":"Nat Genet"},{"key":"1_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1089\/hum.2009.182","volume":"21","author":"S Boutin","year":"2010","unstructured":"Boutin S, Monteilhet V, Veron P et al (2010) Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Hum Gene Ther 21:704\u2013712","journal-title":"Hum Gene Ther"},{"key":"1_CR6","doi-asserted-by":"publisher","first-page":"6344","DOI":"10.1128\/JVI.78.12.6344-6359.2004","volume":"78","author":"CS Peden","year":"2004","unstructured":"Peden CS, Burger C, Muzyczka N et al (2004) Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain. J Virol 78:6344\u20136359","journal-title":"J Virol"},{"key":"1_CR7","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/mt.2008.284","volume":"17","author":"CS Peden","year":"2009","unstructured":"Peden CS, Manfredsson FP, Reimsnider SK et al (2009) Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented. Mol Ther 17:524\u2013537","journal-title":"Mol Ther"},{"issue":"Suppl 1","key":"1_CR8","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1038\/sj.gt.3302612","volume":"12","author":"R Alba","year":"2005","unstructured":"Alba R, Bosch A, Chillon M (2005) Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther 12(Suppl 1):S18\u2013S27","journal-title":"Gene Ther"},{"issue":"Suppl 1","key":"1_CR9","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1038\/sj.gt.3302619","volume":"12","author":"P Gallo","year":"2005","unstructured":"Gallo P, Dharmapuri S, Cipriani B et al (2005) Adenovirus as vehicle for anticancer genetic immunotherapy. Gene Ther 12(Suppl 1):S84\u2013S91","journal-title":"Gene Ther"},{"key":"1_CR10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-1-4939-3271-9_8","volume":"1382","author":"MJ Benskey","year":"2016","unstructured":"Benskey MJ, Manfredsson FP (2016) Lentivirus production and purification. Methods Mol Biol 1382:107\u2013114","journal-title":"Methods Mol Biol"},{"key":"1_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/978-1-4939-3271-9_12","volume":"1382","author":"K Kobayashi","year":"2016","unstructured":"Kobayashi K, Kato S, Inoue K et al (2016) Altering entry site preference of lentiviral vectors into neuronal cells by pseudotyping with envelope glycoproteins. Methods Mol Biol 1382:175\u2013186","journal-title":"Methods Mol Biol"},{"key":"1_CR12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.expneurol.2010.10.016","volume":"228","author":"JR Cannon","year":"2011","unstructured":"Cannon JR, Sew T, Montero L et al (2011) Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra. Exp Neurol 228:41\u201352","journal-title":"Exp Neurol"},{"key":"1_CR13","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/978-1-4419-1132-2_10","volume":"655","author":"P Marconi","year":"2009","unstructured":"Marconi P, Argnani R, Epstein AL et al (2009) HSV as a vector in vaccine development and gene therapy. Adv Exp Med Biol 655:118\u2013144","journal-title":"Adv Exp Med Biol"},{"key":"1_CR14","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1128\/JVI.02029-09","volume":"84","author":"SE Antinone","year":"2010","unstructured":"Antinone SE, Smith GA (2010) Retrograde axon transport of herpes simplex virus and pseudorabies virus: a live-cell comparative analysis. J Virol 84:1504\u20131512","journal-title":"J Virol"},{"key":"1_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1472-6750-7-22","volume":"7","author":"F Schmeisser","year":"2007","unstructured":"Schmeisser F, Weir JP (2007) Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes. BMC Biotechnol 7:22","journal-title":"BMC Biotechnol"},{"key":"1_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.expneurol.2011.03.013","volume":"229","author":"FP Manfredsson","year":"2011","unstructured":"Manfredsson FP, Mandel RJ (2011) The development of flexible lentiviral vectors for gene transfer in the CNS. Exp Neurol 229:201\u2013206","journal-title":"Exp Neurol"},{"key":"1_CR17","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1089\/hum.2007.082","volume":"18","author":"S Kato","year":"2007","unstructured":"Kato S, Inoue K, Kobayashi K et al (2007) Efficient gene transfer via retrograde transport in rodent and primate brains using a human immunodeficiency virus type 1-based vector pseudotyped with rabies virus glycoprotein. Hum Gene Ther 18:1141\u20131151","journal-title":"Hum Gene Ther"},{"key":"1_CR18","doi-asserted-by":"publisher","first-page":"5902","DOI":"10.1128\/JVI.77.10.5902-5910.2003","volume":"77","author":"PL Sinn","year":"2003","unstructured":"Sinn PL, Hickey MA, Staber PD et al (2003) Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol 77:5902\u20135910","journal-title":"J Virol"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.2174\/1566523054546224","volume":"5","author":"J Cronin","year":"2005","unstructured":"Cronin J, Zhang XY, Reiser J (2005) Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther 5:387\u2013398","journal-title":"Curr Gene Ther"},{"key":"1_CR20","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","volume":"78","author":"G Gao","year":"2004","unstructured":"Gao G, Vandenberghe LH, Alvira MR et al (2004) Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol 78:6381\u20136388","journal-title":"J Virol"},{"key":"1_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/978-1-4939-3271-9_11","volume":"1382","author":"D Marsic","year":"2016","unstructured":"Marsic D, Zolotukhin S (2016) Altering tropism of rAAV by directed evolution. Methods Mol Biol 1382:151\u2013173","journal-title":"Methods Mol Biol"},{"key":"1_CR22","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/nrg3927","volume":"16","author":"MS Packer","year":"2015","unstructured":"Packer MS, Liu DR (2015) Methods for the directed evolution of proteins. Nat Rev Genet 16:379\u2013394","journal-title":"Nat Rev Genet"},{"key":"1_CR23","first-page":"3819","volume":"62","author":"E Kienle","year":"2012","unstructured":"Kienle E, Senis E, Borner K et al (2012) Engineering and evolution of synthetic adeno-associated virus (AAV) gene therapy vectors via DNA family shuffling. J Vis Exp 62:3819","journal-title":"J Vis Exp"},{"key":"1_CR24","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1038\/nbt856","volume":"21","author":"OJ Muller","year":"2003","unstructured":"Muller OJ, Kaul F, Weitzman MD et al (2003) Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors. Nat Biotechnol 21:1040\u20131046","journal-title":"Nat Biotechnol"},{"key":"1_CR25","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1038\/mt.2014.139","volume":"22","author":"D Marsic","year":"2014","unstructured":"Marsic D, Govindasamy L, Currlin S et al (2014) Vector design Tour de Force: integrating combinatorial and rational approaches to derive novel adeno-associated virus variants. Mol Ther 22:1900\u20131909","journal-title":"Mol Ther"},{"key":"1_CR26","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fmicb.2011.00204","volume":"2","author":"M Bartel","year":"2011","unstructured":"Bartel M, Schaffer D, Buning H (2011) Enhancing the clinical potential of AAV vectors by capsid engineering to evade pre-existing immunity. Front Microbiol 2:204","journal-title":"Front Microbiol"},{"key":"1_CR27","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1021\/bc100477g","volume":"22","author":"ED Horowitz","year":"2011","unstructured":"Horowitz ED, Weinberg MS, Asokan A (2011) Glycated AAV vectors: chemical redirection of viral tissue tropism. Bioconjug Chem 22:529\u2013532","journal-title":"Bioconjug Chem"},{"key":"1_CR28","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.virol.2008.08.027","volume":"381","author":"L Zhong","year":"2008","unstructured":"Zhong L, Li B, Jayandharan G et al (2008) Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression. Virology 381:194\u2013202","journal-title":"Virology"},{"key":"1_CR29","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.omtn.2017.06.011","volume":"8","author":"NM Kanaan","year":"2017","unstructured":"Kanaan NM, Sellnow RC, Boye SL et al (2017) Rationally engineered AAV capsids improve transduction and volumetric spread in the CNS. Mol Ther Nucleic Acids 8:184\u2013197","journal-title":"Mol Ther Nucleic Acids"},{"key":"1_CR30","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/JVI.00200-16","volume":"90","author":"SL Boye","year":"2016","unstructured":"Boye SL, Bennett A, Scalabrino ML et al (2016) Impact of heparan sulfate binding on transduction of retina by recombinant adeno-associated virus vectors. J Virol 90:4215\u20134231","journal-title":"J Virol"},{"key":"1_CR31","first-page":"G420","volume":"312","author":"BD Gulbransen","year":"2017","unstructured":"Gulbransen BD (2017) Emerging tools to study enteric neuromuscular function. Am J Physiol 312:G420\u2013G426","journal-title":"Am J Physiol"},{"key":"1_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4939-3271-9_3","volume":"1382","author":"T Bjorklund","year":"2016","unstructured":"Bjorklund T (2016) Expression of multiple functional RNAs or proteins from one viral vector. Methods Mol Biol 1382:41\u201356","journal-title":"Methods Mol Biol"},{"key":"1_CR33","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/gt.2013.71","volume":"21","author":"ND Fagoe","year":"2014","unstructured":"Fagoe ND, Eggers R, Verhaagen J et al (2014) A compact dual promoter adeno-associated viral vector for efficient delivery of two genes to dorsal root ganglion neurons. Gene Ther 21:242\u2013252","journal-title":"Gene Ther"},{"key":"1_CR34","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nbt1049","volume":"23","author":"M Amendola","year":"2005","unstructured":"Amendola M, Venneri MA, Biffi A et al (2005) Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat Biotechnol 23:108\u2013116","journal-title":"Nat Biotechnol"},{"key":"1_CR35","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnmol.2018.00036","volume":"11","author":"MJ Benskey","year":"2018","unstructured":"Benskey MJ, Sellnow RC, Sandoval IM et al (2018) Silencing alpha synuclein in mature nigral neurons results in rapid neuroinflammation and subsequent toxicity. Front Mol Neurosci 11:36","journal-title":"Front Mol Neurosci"},{"key":"1_CR36","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1089\/hum.2010.245","volume":"22","author":"SJ Gray","year":"2011","unstructured":"Gray SJ, Foti SB, Schwartz JW et al (2011) Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors. Hum Gene Ther 22:1143\u20131153","journal-title":"Hum Gene Ther"},{"key":"1_CR37","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/mtm.2013.5","volume":"1","author":"CN Leeuw de","year":"2014","unstructured":"de Leeuw CN, Dyka FM, Boye SL et al (2014) Targeted CNS delivery using human minipromoters and demonstrated compatibility with adeno-associated viral vectors. Mol Ther Methods Clin Dev 1:5","journal-title":"Mol Ther Methods Clin Dev"},{"key":"1_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2174\/1566523044578095","volume":"4","author":"SM Ngoi","year":"2004","unstructured":"Ngoi SM, Chien AC, Lee CG (2004) Exploiting internal ribosome entry sites in gene therapy vector design. Curr Gene Ther 4:15\u201331","journal-title":"Curr Gene Ther"},{"key":"1_CR39","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1006\/mthe.2000.0050","volume":"1","author":"H Mizuguchi","year":"2000","unstructured":"Mizuguchi H, Xu Z, Ishii-Watabe A et al (2000) IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther 1:376\u2013382","journal-title":"Mol Ther"},{"key":"1_CR40","doi-asserted-by":"publisher","first-page":"e18556","DOI":"10.1371\/journal.pone.0018556","volume":"6","author":"JH Kim","year":"2011","unstructured":"Kim JH, Lee SR, Li LH et al (2011) High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One 6:e18556","journal-title":"PLoS One"},{"key":"1_CR41","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1099\/0022-1317-82-5-1013","volume":"82","author":"ML Donnelly","year":"2001","unstructured":"Donnelly ML, Luke G, Mehrotra A et al (2001) Analysis of the aphthovirus 2A\/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip. J Gen Virol 82:1013\u20131025","journal-title":"J Gen Virol"},{"key":"1_CR42","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1099\/0022-1317-82-5-1027","volume":"82","author":"ML Donnelly","year":"2001","unstructured":"Donnelly ML, Hughes LE, Luke G et al (2001) The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J Gen Virol 82:1027\u20131041","journal-title":"J Gen Virol"},{"key":"1_CR43","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1038\/s41598-017-02460-2","volume":"7","author":"Z Liu","year":"2017","unstructured":"Liu Z, Chen O, Wall JBJ et al (2017) Systematic comparison of 2A peptides for cloning multi-genes in a polycistronic vector. Sci Rep 7:2193","journal-title":"Sci Rep"},{"key":"1_CR44","first-page":"1648","volume":"16","author":"DM McCarty","year":"2008","unstructured":"McCarty DM (2008) Self-complementary AAV vectors; advances and applications. Molecular therapy : the journal of the American Society of. Gene Ther 16:1648\u20131656","journal-title":"Gene Ther"},{"key":"1_CR45","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1586\/ehm.11.48","volume":"4","author":"D Raj","year":"2011","unstructured":"Raj D, Davidoff AM, Nathwani AC (2011) Self-complementary adeno-associated viral vectors for gene therapy of hemophilia B: progress and challenges. Expert Rev Hematol 4:539\u2013549","journal-title":"Expert Rev Hematol"},{"key":"1_CR46","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1038\/sj.gt.3301514","volume":"8","author":"DM McCarty","year":"2001","unstructured":"McCarty DM, Monahan PE, Samulski RJ (2001) Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther 8:1248\u20131254","journal-title":"Gene Ther"},{"key":"1_CR47","doi-asserted-by":"publisher","first-page":"7025","DOI":"10.1523\/JNEUROSCI.1954-08.2008","volume":"28","author":"D Atasoy","year":"2008","unstructured":"Atasoy D, Aponte Y, Su HH et al (2008) A FLEX switch targets Channelrhodopsin-2 to multiple cell types for imaging and long-range circuit mapping. J Neurosci 28:7025\u20137030","journal-title":"J Neurosci"},{"key":"1_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3389\/fncir.2012.00047","volume":"6","author":"A Saunders","year":"2012","unstructured":"Saunders A, Johnson CA, Sabatini BL (2012) Novel recombinant adeno-associated viruses for Cre activated and inactivated transgene expression in neurons. Front Neural Circuits 6:47","journal-title":"Front Neural Circuits"},{"key":"1_CR49","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/nbt811","volume":"21","author":"F Schnutgen","year":"2003","unstructured":"Schnutgen F, Doerflinger N, Calleja C et al (2003) A directional strategy for monitoring Cre-mediated recombination at the cellular level in the mouse. Nat Biotechnol 21:562\u2013565","journal-title":"Nat Biotechnol"},{"key":"1_CR50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/978-1-4939-3271-9_2","volume":"1382","author":"ML Hirsch","year":"2016","unstructured":"Hirsch ML, Wolf SJ, Samulski RJ (2016) Delivering transgenic DNA exceeding the carrying capacity of AAV vectors. Methods Mol Biol 1382:21\u201339","journal-title":"Methods Mol Biol"},{"key":"1_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/mt.2009.258","volume":"18","author":"B Dong","year":"2010","unstructured":"Dong B, Nakai H, Xiao W (2010) Characterization of genome integrity for oversized recombinant AAV vector. Mol Ther 18:87\u201392","journal-title":"Mol Ther"},{"key":"1_CR52","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mt.2009.255","volume":"18","author":"Z Wu","year":"2010","unstructured":"Wu Z, Yang H, Colosi P (2010) Effect of genome size on AAV vector packaging. Mol Ther 18:80\u201386","journal-title":"Mol Ther"},{"key":"1_CR53","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1006\/mthe.2001.0456","volume":"4","author":"D Duan","year":"2001","unstructured":"Duan D, Yue Y, Engelhardt JF (2001) Expanding AAV packaging capacity with trans-splicing or overlapping vectors: a quantitative comparison. Mol Ther 4:383\u2013391","journal-title":"Mol Ther"},{"key":"1_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/mt.2009.280","volume":"18","author":"ML Hirsch","year":"2010","unstructured":"Hirsch ML, Agbandje-McKenna M, Samulski RJ (2010) Little vector, big gene transduction: fragmented genome reassembly of adeno-associated virus. Mol Ther 18:6\u20138","journal-title":"Mol Ther"},{"key":"1_CR55","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.bbrc.2010.09.131","volume":"402","author":"CC Hsu","year":"2010","unstructured":"Hsu CC, Li HP, Hung YH et al (2010) Targeted methylation of CMV and E1A viral promoters. Biochem Biophys Res Commun 402:228\u2013234","journal-title":"Biochem Biophys Res Commun"},{"key":"1_CR56","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2174\/1566523044578077","volume":"4","author":"ED Papadakis","year":"2004","unstructured":"Papadakis ED, Nicklin SA, Baker AH et al (2004) Promoters and control elements: designing expression cassettes for gene therapy. Curr Gene Ther 4:89\u2013113","journal-title":"Curr Gene Ther"},{"key":"1_CR57","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","volume":"108","author":"H Niwa","year":"1991","unstructured":"Niwa H, Yamamura K, Miyazaki J (1991) Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193\u2013199","journal-title":"Gene"},{"key":"1_CR58","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0092-8674(86)90519-2","volume":"47","author":"K Gorski","year":"1986","unstructured":"Gorski K, Carneiro M, Schibler U (1986) Tissue-specific in vitro transcription from the mouse albumin promoter. Cell 47:767\u2013776","journal-title":"Cell"},{"key":"1_CR59","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1016\/S0021-9258(18)53537-7","volume":"268","author":"H Rindt","year":"1993","unstructured":"Rindt H, Gulick J, Knotts S et al (1993) In vivo analysis of the murine beta-myosin heavy chain gene promoter. J Biol Chem 268:5332\u20135338","journal-title":"J Biol Chem"},{"key":"1_CR60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4939-3271-9_6","volume":"1382","author":"S Kugler","year":"2016","unstructured":"Kugler S (2016) Tissue-specific promoters in the CNS. Methods Mol Biol 1382:81\u201391","journal-title":"Methods Mol Biol"},{"key":"1_CR61","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1073\/pnas.0409141102","volume":"102","author":"ZZ Su","year":"2005","unstructured":"Su ZZ, Sarkar D, Emdad L et al (2005) Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter. Proc Natl Acad Sci U S A 102:1059\u20131064","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR62","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.neulet.2012.09.059","volume":"530","author":"EE Wettergren","year":"2012","unstructured":"Wettergren EE, Gussing F, Quintino L et al (2012) Novel disease-specific promoters for use in gene therapy for Parkinson's disease. Neurosci Lett 530:29\u201334","journal-title":"Neurosci Lett"},{"key":"1_CR63","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1038\/sj.gt.3301823","volume":"9","author":"O Greco","year":"2002","unstructured":"Greco O, Marples B, Dachs GU et al (2002) Novel chimeric gene promoters responsive to hypoxia and ionizing radiation. Gene Ther 9:1403\u20131411","journal-title":"Gene Ther"},{"key":"1_CR64","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/nbt734","volume":"20","author":"S Shimizu-Sato","year":"2002","unstructured":"Shimizu-Sato S, Huq E, Tepperman JM et al (2002) A light-switchable gene promoter system. Nat Biotechnol 20:1041\u20131044","journal-title":"Nat Biotechnol"},{"key":"1_CR65","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1006\/mthe.2001.0299","volume":"3","author":"R Chen","year":"2001","unstructured":"Chen R, Meseck ML, Woo SL (2001) Auto-regulated hepatic insulin gene expression in type 1 diabetic rats. Mol Ther 3:584\u2013590","journal-title":"Mol Ther"},{"key":"1_CR66","doi-asserted-by":"publisher","first-page":"16589","DOI":"10.1073\/pnas.1009158107","volume":"107","author":"E Portales-Casamar","year":"2010","unstructured":"Portales-Casamar E, Swanson DJ, Liu L et al (2010) A regulatory toolbox of MiniPromoters to drive selective expression in the brain. Proc Natl Acad Sci U S A 107:16589\u201316594","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR67","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.gene.2017.10.079","volume":"644","author":"M Majewska","year":"2018","unstructured":"Majewska M, Wysokinska H, Kuzma L et al (2018) Eukaryotic and prokaryotic promoter databases as valuable tools in exploring the regulation of gene transcription: a comprehensive overview. Gene 644:38\u201348","journal-title":"Gene"},{"key":"1_CR68","doi-asserted-by":"publisher","first-page":"D51","DOI":"10.1093\/nar\/gkw1069","volume":"45","author":"R Dreos","year":"2017","unstructured":"Dreos R, Ambrosini G, Groux R et al (2017) The eukaryotic promoter database in its 30th year: focus on non-vertebrate organisms. Nucleic Acids Res 45:D51\u2013D55","journal-title":"Nucleic Acids Res"},{"key":"1_CR69","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gku1111","volume":"43","author":"R Dreos","year":"2015","unstructured":"Dreos R, Ambrosini G, Perier RC et al (2015) The Eukaryotic Promoter Database: expansion of EPDnew and new promoter analysis tools. Nucleic Acids Res 43:D92\u2013D96","journal-title":"Nucleic Acids Res"},{"key":"1_CR70","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1073\/pnas.89.12.5547","volume":"89","author":"M Gossen","year":"1992","unstructured":"Gossen M, Bujard H (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci U S A 89:5547\u20135551","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR71","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1038\/mt.2009.196","volume":"17","author":"FP Manfredsson","year":"2009","unstructured":"Manfredsson FP, Burger C, Rising AC et al (2009) Tight Long-term dynamic doxycycline responsive nigrostriatal GDNF using a single rAAV vector. Mol Ther 17:1857\u20131867","journal-title":"Mol Ther"},{"key":"1_CR72","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.expneurol.2006.11.014","volume":"204","author":"A Chtarto","year":"2007","unstructured":"Chtarto A, Yang X, Bockstael O et al (2007) Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector. Exp Neurol 204:387\u2013399","journal-title":"Exp Neurol"},{"key":"1_CR73","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1038\/mt.2013.169","volume":"21","author":"L Quintino","year":"2013","unstructured":"Quintino L, Manfre G, Wettergren EE et al (2013) Functional neuroprotection and efficient regulation of GDNF using destabilizing domains in a rodent model of Parkinson's disease. Mol ther 21:2169\u20132180","journal-title":"Mol ther"},{"key":"1_CR74","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/978-1-4939-3271-9_4","volume":"1382","author":"L Breger","year":"2016","unstructured":"Breger L, Wettergren EE, Quintino L et al (2016) Regulated gene therapy. Methods Mol Biol 1382:57\u201366","journal-title":"Methods Mol Biol"},{"key":"1_CR75","doi-asserted-by":"publisher","first-page":"e27639","DOI":"10.4161\/trns.27369","volume":"5","author":"AG Arimbasseri","year":"2014","unstructured":"Arimbasseri AG, Rijal K, Maraia RJ (2014) Comparative overview of RNA polymerase II and III transcription cycles, with focus on RNA polymerase III termination and reinitiation. Transcription 5:e27639","journal-title":"Transcription"},{"key":"1_CR76","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1093\/nar\/28.6.1283","volume":"28","author":"MR Paule","year":"2000","unstructured":"Paule MR, White RJ (2000) Survey and summary: transcription by RNA polymerases I and III. Nucleic Acids Res 28:1283\u20131298","journal-title":"Nucleic Acids Res"},{"key":"1_CR77","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1101\/gad.1026202","volume":"16","author":"JE Butler","year":"2002","unstructured":"Butler JE, Kadonaga JT (2002) The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev 16:2583\u20132592","journal-title":"Genes Dev"},{"key":"1_CR78","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1038\/mtna.2014.12","volume":"3","author":"H Ma","year":"2014","unstructured":"Ma H, Wu Y, Dang Y et al (2014) Pol III promoters to express small RNAs: delineation of transcription initiation. Mol Ther Nucleic Acids 3:e161","journal-title":"Mol Ther Nucleic Acids"},{"key":"1_CR79","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/84397","volume":"19","author":"J Nakai","year":"2001","unstructured":"Nakai J, Ohkura M, Imoto K (2001) A high signal-to-noise Ca(2+) probe composed of a single green fluorescent protein. Nat Biotechnol 19:137\u2013141","journal-title":"Nat Biotechnol"},{"key":"1_CR80","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nmeth.1399","volume":"6","author":"E Dreosti","year":"2009","unstructured":"Dreosti E, Odermatt B, Dorostkar MM et al (2009) A genetically encoded reporter of synaptic activity in vivo. Nat Methods 6:883\u2013889","journal-title":"Nat Methods"},{"key":"1_CR81","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fnmol.2011.00034","volume":"4","author":"H Li","year":"2011","unstructured":"Li H, Foss SM, Dobryy YL et al (2011) Concurrent imaging of synaptic vesicle recycling and calcium dynamics. Front Mol Neurosci 4:34","journal-title":"Front Mol Neurosci"},{"key":"1_CR82","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.neuron.2012.08.040","volume":"76","author":"N Nikolaou","year":"2012","unstructured":"Nikolaou N, Lowe AS, Walker AS et al (2012) Parametric functional maps of visual inputs to the tectum. Neuron 76:317\u2013324","journal-title":"Neuron"},{"key":"1_CR83","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nmeth.1398","volume":"6","author":"L Tian","year":"2009","unstructured":"Tian L, Hires SA, Mao T et al (2009) Imaging neural activity in worms, flies and mice with improved GCaMP calcium indicators. Nat Methods 6:875\u2013881","journal-title":"Nat Methods"},{"key":"1_CR84","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1126\/science.1208592","volume":"333","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Araki S, Wu J et al (2011) An expanded palette of genetically encoded Ca(2)(+) indicators. Science 333:1888\u20131891","journal-title":"Science"},{"key":"1_CR85","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3389\/fnmol.2013.00002","volume":"6","author":"J Akerboom","year":"2013","unstructured":"Akerboom J, Carreras Calderon N, Tian L et al (2013) Genetically encoded calcium indicators for multi-color neural activity imaging and combination with optogenetics. Front Mol Neurosci 6:2","journal-title":"Front Mol Neurosci"},{"key":"1_CR86","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3389\/fncir.2013.00034","volume":"7","author":"AS Walker","year":"2013","unstructured":"Walker AS, Burrone J, Meyer MP (2013) Functional imaging in the zebrafish retinotectal system using RGECO. Front Neural Circuits 7:34","journal-title":"Front Neural Circuits"},{"key":"1_CR87","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0896-6273(00)80955-1","volume":"19","author":"MS Siegel","year":"1997","unstructured":"Siegel MS, Isacoff EY (1997) A genetically encoded optical probe of membrane voltage. Neuron 19:735\u2013741","journal-title":"Neuron"},{"key":"1_CR88","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1046\/j.0953-816x.2001.01617.x","volume":"13","author":"R Sakai","year":"2001","unstructured":"Sakai R, Repunte-Canonigo V, Raj CD et al (2001) Design and characterization of a DNA-encoded, voltage-sensitive fluorescent protein. Eur J Neurosci 13:2314\u20132318","journal-title":"Eur J Neurosci"},{"key":"1_CR89","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S0006-3495(02)75415-5","volume":"82","author":"K Ataka","year":"2002","unstructured":"Ataka K, Pieribone VA (2002) A genetically targetable fluorescent probe of channel gating with rapid kinetics. Biophys J 82:509\u2013516","journal-title":"Biophys J"},{"key":"1_CR90","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.chembiol.2009.11.014","volume":"16","author":"A Perron","year":"2009","unstructured":"Perron A, Mutoh H, Launey T et al (2009) Red-shifted voltage-sensitive fluorescent proteins. Chem Biol 16:1268\u20131277","journal-title":"Chem Biol"},{"key":"1_CR91","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/28190","volume":"394","author":"G Miesenbock","year":"1998","unstructured":"Miesenbock G, De Angelis DA, Rothman JE (1998) Visualizing secretion and synaptic transmission with pH-sensitive green fluorescent proteins. Nature 394:192\u2013195","journal-title":"Nature"},{"key":"1_CR92","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.neuron.2006.08.029","volume":"51","author":"B Granseth","year":"2006","unstructured":"Granseth B, Odermatt B, Royle SJ et al (2006) Clathrin-mediated endocytosis is the dominant mechanism of vesicle retrieval at hippocampal synapses. Neuron 51:773\u2013786","journal-title":"Neuron"},{"key":"1_CR93","doi-asserted-by":"publisher","first-page":"20576","DOI":"10.1073\/pnas.0707574105","volume":"104","author":"J Balaji","year":"2007","unstructured":"Balaji J, Ryan TA (2007) Single-vesicle imaging reveals that synaptic vesicle exocytosis and endocytosis are coupled by a single stochastic mode. Proc Natl Acad Sci U S A 104:20576\u201320581","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR94","doi-asserted-by":"publisher","first-page":"13044","DOI":"10.1074\/jbc.M312846200","volume":"279","author":"GT Hanson","year":"2004","unstructured":"Hanson GT, Aggeler R, Oglesbee D et al (2004) Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J Biol Chem 279:13044\u201313053","journal-title":"J Biol Chem"},{"key":"1_CR95","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/nn1525","volume":"8","author":"ES Boyden","year":"2005","unstructured":"Boyden ES, Zhang F, Bamberg E et al (2005) Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci 8:1263\u20131268","journal-title":"Nat Neurosci"},{"key":"1_CR96","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nature05744","volume":"446","author":"F Zhang","year":"2007","unstructured":"Zhang F, Wang LP, Brauner M et al (2007) Multimodal fast optical interrogation of neural circuitry. Nature 446:633\u2013639","journal-title":"Nature"},{"key":"1_CR97","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.cub.2016.03.007","volume":"26","author":"K Spoida","year":"2016","unstructured":"Spoida K, Eickelbeck D, Karapinar R et al (2016) Melanopsin variants as intrinsic optogenetic on and off switches for transient versus sustained activation of G protein pathways. Curr Biol 26:1206\u20131212","journal-title":"Curr Biol"},{"key":"1_CR98","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.brainres.2012.09.043","volume":"1511","author":"MS Farrell","year":"2013","unstructured":"Farrell MS, Roth BL (2013) Pharmacosynthetics: reimagining the pharmacogenetic approach. Brain Res 1511:6\u201320","journal-title":"Brain Res"},{"key":"1_CR99","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.neuron.2009.06.014","volume":"63","author":"GM Alexander","year":"2009","unstructured":"Alexander GM, Rogan SC, Abbas AI et al (2009) Remote control of neuronal activity in transgenic mice expressing evolved G protein-coupled receptors. Neuron 63:27\u201339","journal-title":"Neuron"},{"key":"1_CR100","doi-asserted-by":"publisher","first-page":"5163","DOI":"10.1073\/pnas.0700293104","volume":"104","author":"BN Armbruster","year":"2007","unstructured":"Armbruster BN, Li X, Pausch MH et al (2007) Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc Natl Acad Sci U S A 104:5163\u20135168","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1_CR101","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/1743-422X-10-74","volume":"10","author":"BL Ellis","year":"2013","unstructured":"Ellis BL, Hirsch ML, Barker JC et al (2013) A survey of ex vivo\/in vitro transduction efficiency of mammalian primary cells and cell lines with Nine natural adeno-associated virus (AAV1-9) and one engineered adeno-associated virus serotype. Virol J 10:74","journal-title":"Virol J"},{"key":"1_CR102","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s12033-012-9528-5","volume":"53","author":"W Denning","year":"2013","unstructured":"Denning W, Das S, Guo S et al (2013) Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycations. Mol Biotechnol 53:308\u2013314","journal-title":"Mol Biotechnol"},{"key":"1_CR103","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1056\/NEJMoa012616","volume":"346","author":"S Hacein-Bey-Abina","year":"2002","unstructured":"Hacein-Bey-Abina S, Le Deist F, Carlier F et al (2002) Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346:1185\u20131193","journal-title":"N Engl J Med"},{"key":"1_CR104","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm1239","volume":"11","author":"MH Tuszynski","year":"2005","unstructured":"Tuszynski MH, Thal L, Pay M et al (2005) A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11:551\u2013555","journal-title":"Nat Med"},{"key":"1_CR105","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.stemcr.2014.10.013","volume":"4","author":"HL Li","year":"2015","unstructured":"Li HL, Fujimoto N, Sasakawa N et al (2015) Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. Stem Cell Reports 4:143\u2013154","journal-title":"Stem Cell Reports"},{"key":"1_CR106","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coviro.2016.07.006","volume":"21","author":"D Duan","year":"2016","unstructured":"Duan D (2016) Systemic delivery of adeno-associated viral vectors. Curr Opin Virol 21:16\u201325","journal-title":"Curr Opin Virol"},{"key":"1_CR107","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","volume":"16","author":"C Zincarelli","year":"2008","unstructured":"Zincarelli C, Soltys S, Rengo G et al (2008) Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther 16:1073\u20131080","journal-title":"Mol Ther"},{"key":"1_CR108","doi-asserted-by":"crossref","first-page":"4600","DOI":"10.1182\/blood.V91.12.4600","volume":"91","author":"H Nakai","year":"1998","unstructured":"Nakai H, Herzog RW, Hagstrom JN et al (1998) Adeno-associated viral vector-mediated gene transfer of human blood coagulation factor IX into mouse liver. Blood 91:4600\u20134607","journal-title":"Blood"},{"key":"1_CR109","first-page":"Unit14D.12","volume":"Chapter 14","author":"AM Gruntman","year":"2012","unstructured":"Gruntman AM, Mueller C, Flotte TR et al (2012) Gene transfer in the lung using recombinant adeno-associated virus. Curr Protoc Microbiol Chapter 14:Unit14D.12","journal-title":"Curr Protoc Microbiol"},{"key":"1_CR110","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-4939-3271-9_14","volume":"1382","author":"MJ Benskey","year":"2016","unstructured":"Benskey MJ, Manfredsson FP (2016) Intraparenchymal Stereotaxic Delivery of rAAV and Special Considerations in Vector Handling. Methods Mol Biol 1382:199\u2013215","journal-title":"Methods Mol Biol"}],"container-title":["Methods in Molecular Biology","Viral Vectors for Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-9065-8_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T05:35:44Z","timestamp":1662874544000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-9065-8_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9781493990641","9781493990658"],"references-count":110,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-9065-8_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"1 February 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}